Comparison of bupivacaine and dexmedetomidine femoral and sciatic nerve blocks with bupivacaine and buprenorphine epidural injection for stifle arthroplasty in dogs

To compare the quality of anesthesia and analgesia from femoral and sciatic nerve blocks (FS) with bupivacaine and dexmedetomidine with that from an epidural injection (EPI) with bupivacaine and buprenorphine in dogs undergoing unilateral stifle arthroplasty. Prospective, blinded, randomized, clinic...

Full description

Saved in:

Bibliographic Details
Published in:	Veterinary anaesthesia and analgesia Vol. 43; no. 4; p. 435
Main Authors:	Bartel, Annatasha Kg, Campoy, Luis, Martin-Flores, Manuel, Gleed, Robin D, Walker, Kyle J, Scanapico, Courtney E, Reichard, Alison B
Format:	Journal Article
Language:	English
Published:	United States 01-07-2016
Subjects:	Analgesia - methods Analgesia - veterinary Analgesics, Non-Narcotic Anesthesia - veterinary Anesthetics, Local Animals Arthroplasty - veterinary Bupivacaine - administration & dosage Buprenorphine - administration & dosage Dexmedetomidine - administration & dosage Dogs Femoral Nerve - drug effects Injections, Epidural - veterinary Nerve Block - methods Nerve Block - veterinary Pain Measurement - methods Pain Measurement - veterinary Pain, Postoperative - diagnosis Pain, Postoperative - veterinary Prospective Studies Sciatic Nerve - drug effects Stifle - surgery sciatic nerve block dexmedetomidine buprenorphine epidural femoral nerve block bupivacaine
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	To compare the quality of anesthesia and analgesia from femoral and sciatic nerve blocks (FS) with bupivacaine and dexmedetomidine with that from an epidural injection (EPI) with bupivacaine and buprenorphine in dogs undergoing unilateral stifle arthroplasty. Prospective, blinded, randomized, clinical comparison. Twenty-six dogs weighing 36 ± 10 kg and aged 5 (1-11) years. Dogs were randomly assigned to either FS [n = 13; bupivacaine 0.5% (0.5 mg kg(-1) ) plus dexmedetomidine (0.1 μg kg(-1) ) for each nerve] or EPI [n = 13; bupivacaine 0.5% (1 mg kg(-1) ) plus buprenorphine (4 μg kg(-1) )]. Data collected included intraoperative cardiopulmonary variables and postoperative pain scores (Glasgow Composite Pain Scale), sedation scores, opioid consumption, time to urination and time to return of various behaviors. Rescue analgesia (hydromorphone 0.05 mg kg(-1) ) was administered intravenously whenever pain scores were ≥ 6/24. Subsequent data from rescued dogs were excluded from further analysis. No differences were found for any of the variables evaluated during and after anesthesia. Over 60% (nine dogs in FS, eight dogs in EPI) of patients from either group did not need additional analgesia within the 24 hour observational period. Three and four patients in FS and EPI, respectively, that required rescue analgesia did so within the first 30 minutes after extubation; only one patient in EPI required supplemental analgesia more than 4 hours after extubation. One patient in each group did not urinate spontaneously for 24 hours. Both techniques have the potential to provide sufficient analgesia for up to 24 hours in approximately two-thirds of dogs. Careful observation for signs of pain and preparedness to intervene is still recommended. The incidence of urinary retention was low in both groups. These techniques show promise for providing high-quality analgesia for stifle arthroplasty.
ISSN:	1467-2995
DOI:	10.1111/vaa.12318